Heart transplantation using bivalirudin as anticoagulant

Sinan A Simsir; Ernst R Schwarz; Lawrence S C Czer; Solomon I Hamburg

doi:10.1510/icvts.2009.218172

Heart transplantation using bivalirudin as anticoagulant

Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):150-1. doi: 10.1510/icvts.2009.218172. Epub 2009 Oct 1.

Authors

Sinan A Simsir¹, Ernst R Schwarz, Lawrence S C Czer, Solomon I Hamburg

Affiliation

¹ Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. Sinan.simsir@cshs.org

PMID: 19797475
DOI: 10.1510/icvts.2009.218172

Abstract

We present the case of a man with heparin-induced thrombocytopenia (HIT) and acute idiopathic decompensated cardiomyopathy who underwent successful heart transplantation with the use of bivalirudin as anticoagulant.

Publication types

Case Reports

MeSH terms

Adult
Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
Blood Transfusion, Autologous
Cardiomyopathies / surgery*
Cardiopulmonary Bypass
Heart Transplantation*
Heparin / adverse effects
Hirudins
Humans
Immunosuppressive Agents / therapeutic use
Male
Peptide Fragments / therapeutic use*
Recombinant Proteins / therapeutic use
Thrombocytopenia / chemically induced
Transplantation, Homologous
Treatment Outcome

Substances

Anticoagulants
Hirudins
Immunosuppressive Agents
Peptide Fragments
Recombinant Proteins
Heparin
bivalirudin